We Just Bought More Shares of This Dividend Aristocrat (it’s a Free-Cash-Flow Machine)
With our June spend, we’ve reached our target of $5,000 in projected annual income within 7 years of the Income Builder Portfolio’s inception.
Read MorePosted by Mike Nadel, Dividends And Income | Jun 26, 2023
With our June spend, we’ve reached our target of $5,000 in projected annual income within 7 years of the Income Builder Portfolio’s inception.
Read MorePosted by Mike Nadel, Dividends And Income | May 15, 2023
The company has been paying dividends without a reduction since the late 1800s. During the Great Recession — the second-worst financial crisis in modern history — it increased its dividend, suffered a less-than-disastrous revenue decline, and saw its stock price fall only a fraction as much as that of the overall market.
Read MorePosted by Mike Nadel, Dividends And Income | Apr 24, 2023
One of them is a health care juggernaut growing its earnings and dividend like crazy.
Read MorePosted by Mike Nadel, Dividends And Income | Mar 21, 2023
The IBP is in its sixth year, and this is the first time I’ve selected anything other than a stock for it. Here’s what’s going on…
Read MorePosted by Mike Nadel, Dividends And Income | Feb 16, 2023
It’s been a market-crushing performer for the Income Builder Portfolio and it just came out with an outstanding earnings report. And, when it comes to quality, there aren’t many companies out there ranked higher. On top of all this, the company just announced that it will be increasing its dividend by another 10% – one of its largest of the last decade, and the 51st consecutive year with an increase.
Read More